GlassScriptPhysician profile
Venkata Chitturi
NPI 1710095369
$6,840.22
in general payments reported to CMS, 2019-2025
54 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $536 · 2021: $1,105 · 2022: $825 · 2023: $713 · 2024: $2,828 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035 · Travel and Lodging: $961 · Education: $20.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,035.12 |
| Travel and Lodging | $960.69 |
| Education | $20.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,337.20 | 2021-2024 | Vns Therapy |
| Abbvie INC. | $784.77 | 2021-2025 | Ubrelvy |
| Emd Serono, INC. | $525.01 | 2020-2024 | Mavenclad, Mavenclad |
| Neurocrine Biosciences, INC. | $319.28 | 2022-2024 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $302.09 | 2021-2025 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $295.53 | 2019-2025 | |
| Ucb, INC. | $278.31 | 2019-2024 | Briviact, Fintepla |
| Lundbeck LLC | $228.17 | 2021-2025 | Vyepti, Rexulti |
| Biohaven Pharmaceuticals, INC. | $208.08 | 2021 | |
| Amgen INC. | $200.92 | 2021-2022 | |
| Biogen, INC. | $189.47 | 2019-2025 | Vumerity, Avonex, Plegridy |
| Allergan, INC. | $183.48 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $159.86 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $145.95 | 2019-2021 | |
| Lilly USA, LLC | $121.67 | 2021-2024 | Emgality, Amyvid, Jardiance |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkata Chitturi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.